Back to Search
Start Over
NK Cell Therapy Pipeline Booms as 100+ Companies likely to Enter in the Treatment Domain | Major Companies - Cantargia, Cellid, Celyad, and Others
- Source :
- M2 Presswire. April 19, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PRESSWIRE-April 19, 2023-: NK Cell Therapy Pipeline Booms as 100+ Companies likely to Enter in the Treatment Domain | Major Companies - Cantargia, Cellid, Celyad, and Others (C)1994-2023 M2 [...]
- Subjects :
- Merck & Company Inc. -- Product development -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends -- Product development
Nektar Therapeutics -- Forecasts and trends -- Product development
Fate Therapeutics Inc. -- Product development -- Forecasts and trends
Business -- Research
Biotechnology industry -- Forecasts and trends -- Product development
Killer cells -- Reports -- Forecasts and trends
Pharmaceutical industry -- Product development -- Forecasts and trends
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.746126849